Table 2.
Target vessels of study groups
Paclitaxel DCB (n = 429) | Non-paclitaxel 2nd-generation DES (n = 1088) | p value | |
---|---|---|---|
LMS | 10 (2.3) | 34 (3.1) | 0.41 |
LAD | 229 (53.4) | 545 (50.1) | 0.25 |
Cx | 76 (17.7) | 135 (12.4) | < 0.01* |
RCA | 77 (17.9) | 250 (22.9) | 0.03* |
Graft | 4 (0.9) | 27 (2.4) | 0.06 |
Multi-vessel PCI | 33 (7.7) | 97 (8.9) | 0.44 |
Mean vessel diameter, mm | 3.06 ± 0.56 | 3.39 ± 0.59 | < 0.01* |
Mean lesion length, mm | 26.05 ± 11.95 | 30.03 ± 16.52 | < 0.01* |
Large vessels (diameter ≥ 3 mm) | 320 (74.6) | 925 (85) | < 0.01* |
Target vessels treated with DCB or DES
LMS left main stem, LAD left anterior descending artery, Cx circumflex, RCA right coronary artery, PCI percutaneous coronary intervention. Data are n (%) and *denotes significant result